Prospective cohort studies based on the German biologics register (Rheumatoide Arthritis: Beobachtung der Biologika-Therapie [RABBIT]) and Australian Rheumatology Association Database (ARAD) found no difference in the risk of cancer due to TNF inhibitors use [16, 18]. The gene discussed is TNF; the disease is rheumatoid arthritis.